Table 2.
Sensitivity and Specificity to Predict IBD in the Total Discovery Cohort
| Sensitivity (95% CI) | Specificity (95% CI) | |
|---|---|---|
| FOBT and Perianal Examination | 65.9% (54.8-75.8%) | 72.0% (66.0-77.5%) |
| Hematocrit | 59.0% (47.7-69.7%) | 60.4% (53.8-66.8%) |
| Platelets | 33.8% (23.6-45.2%) | 95.5% (91.9-97.8%) |
| Albumin | 18.4% (10.5-29.0%) | 97.4% (94.0-99.2%) |
| CRP | 50.7% (38.4-63.0%) | 89.2% (82.8-93.8%) |
| ESR | 54.4% (42.8-65.6%) | 90.8% (85.9-94.5%) |